查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物技术市场规模、份额、趋势分析：技术（DNA 序列、发酵）、应用（健康、生物资讯学）、地区（北美、欧盟、亚太地区）和分部预测，2022-2030
市场调查报告书
商品编码
1097090

生物技术市场规模、份额、趋势分析：技术（DNA 序列、发酵）、应用（健康、生物资讯学）、地区（北美、欧盟、亚太地区）和分部预测，2022-2030

Biotechnology Market Size, Share & Trends Analysis By Technology (DNA Sequencing, Fermentation), By Application (Health, Bioinformatics), By Region (North America, EU, APAC), And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10个工作天内

价格

生物技术市场的增长和趋势

据正观研究最新报告显示，到2030年，全球生物技术市场规模将达到38795.1亿美元，预测期内復合年增长率为13.9%，

这一市场的驱动因素包括创新和先进技术的出现、大量投资和政府支持生物技术行业的努力，以及对合成生物学应用不断增长的需求。生物科技初创企业获得了强大的资金支持和风险投资，2021年达到410亿美元，比上年的367亿美元增长11%以上。值得注意的几轮融资包括 Charis Life Sciences 2021 年 5 月的 8.3 亿美元用于扩展精准医疗平台和 Avogen 于 2021 年用于 COVID-19 候选疫苗的临床开发。Elevate Bio 每月筹集 7 亿美元的 C 系列资金和2021 年 3 月的 C 轮融资 5.25 亿美元，用于开发细胞和基因治疗技术。

此外，2021年新诞生了28家生物科技独角兽，该领域共有192家独角兽。政府对生物技术基础设施的支持也有助于市场增长。例如，印度 2021-22 年联邦预算包括 2.2794 亿美元的生物技术研发储备金，併计划在该国建立 9 个生物安全三级实验室。此外，Illumina Accelerator 等计划为特定的初创企业提供种子投资、基因组学专业知识以及获得 Illumina 测序系统和试剂的途径，以推动市场增长。

COVID-19 大流行正在寻找新的解决方案来开发疫苗和诊断工具来对抗这种疾病。例如，mRNA疫苗的出现得到了生物技术领域尖端技术的支持，例如加快疫苗开发时间的分子研究工具和基因测序方法。此外，2022 年 3 月，针对 COVID-19 的高灵敏度和简单 PCR 检测 DASH（特异性杂交诊断分析仪）获得 FDA 紧急使用批准。该测试已由 Minute Molecular Diagnostics 商业化，可在 15 分钟内产生结果。分子诊断学的这种进步预计将推动市场增长。

生物技术市场报告亮点

  • 由于高发疾病的流行、对再生医学的日益关注、COVID-19 流行带来的技术创新以及医疗保健基础设施的改善，健康应用领域在 2021 年占据了最大份额。
  • DNA 测序技术部分在 2021 年占据第二大份额，原因是测序成本降低和在精准医疗保健开发中的采用率增加。
  • 2021 年，随着在该地区运营的主要公司推出先进的生物技术解决方案，北美占据了全球市场的最大份额。
  • 预计 2022 年至 2030 年亚太地区的复合年增长率最快。这是由于印度和中国政府的积极努力以及药物批准过程中有利的监管变化。

目录

第 1 章调查方法及范围

  • 调查地点
  • 调查方法
  • 资讯采购
  • 资讯或数据分析
  • 市场製定与验证
  • 世界市场：CAGR 计算
  • 目的
    • 目的 1
    • 目的 2
  • 收入建模：COVID-19 之后的市场情景
    • 当前市场动态评价：公司评价
    • 市场动态评估：未来预测
    • 20 强实体：企业利润和市值分析
      • A部分
      • B部分
      • C部分

第 2 章执行摘要

  • 市场快照

第 3 章市场变量、趋势和范围

  • 市场趋势与展望
  • 市场细分和范围
  • 市场动态
    • 市场促进因素分析
      • 存在有利的政府举措
      • 对农产品的需求不断增加
      • 对合成生物学的需求不断增加
      • DNA测序价格下跌
      • 增加医疗保健费用以支持开发有效的癌症个体化诊断和治疗程序
    • 市场约束分析
      • 道德和法律限制
      • 与转基因生物和作物相关的风险
      • 与 NGS 实施相关的问题
  • 2021 年技术渗透率和增长前景图
  • 2021 年市场份额分析
  • 商业环境分析
    • SWOT 分析；按因素（政治和法律、经济和技术）
    • 波特五力分析

第 4 章生物技术分类：应用评估/趋势分析

  • 生物技术市场：应用波动分析
  • 健康
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球健康生物技术市场（10 亿美元）
  • 粮食及农业组织
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球食品和农业生物技术市场（10 亿美元）
  • 自然资源与环境
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球自然资源与环境生物技术市场（10 亿美元）
  • 工业加工
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球工业加工生物技术市场（10 亿美元）
  • 生物资讯学
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030年全球生物信息学生物技术市场（10亿美元）
  • 其他应用
    • 2018-2030 年全球生物技术应用市场（10 亿美元）

第 5 章生物技术市场分类：技术估计/趋势分析

  • 生物技术市场：技术波动分析
  • DNA测序
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球 DNA 测序生物技术市场（10 亿美元）
  • 纳米生物技术
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球纳米生物技术生物技术市场（10 亿美元）
  • 组织工程与再生
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球组织工程和再生生物技术市场（10 亿美元）
  • 发酵
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 生物製药製造
    • 生物製药和生物技术调查
    • 其他
    • 2018-2030 年全球发酵生物技术市场（10 亿美元）
  • 基于细胞的检测
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球细胞检测生物技术市场（10 亿美元）
  • PCR技术
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年全球 PCR 技术生物技术市场（10 亿美元）
  • 色谱法
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年色谱全球生物技术市场（10 亿美元）
  • 其他技术
    • COVID 之前的细分场景
    • COVID 之后的细分场景
    • 2018-2030 年其他技术的全球生物技术市场（10 亿美元）

第 6 章生物技术市场分类：区域估计/趋势分析，按应用和技术

  • 2021 年和 2030 年区域生物技术份额
  • 北美
    • 美国
    • 加拿大
  • 欧洲
      • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯

第 7 章竞争态势

  • 战略框架
  • 公司简介
    • AstraZeneca
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Gilead Sciences Inc.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Bristol-Myers Squibb
      • 公司简介
      • 新基公司
      • 财务表现
      • 产品基准
      • 战略举措
    • Biogen
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Abbott Laboratories
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Amgen Inc.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Novo Nordisk A/S
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Merck KGaA
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Johnson & Johnson Services
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Novartis AG
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Sanofi
      • 公司简介
      • 健□
      • 财务表现
      • 产品基准
      • 战略举措
    • F. Hoffman-La Roche Co., Ltd.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Pfizer Inc.
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
    • Lonza
      • 公司简介
      • 财务表现
      • 产品基准
      • 战略举措
Product Code: 978-1-68038-134-4

Biotechnology Market Growth & Trends:

The global biotechnology market size is expected to reach USD 3,879.51 billion by 2030, registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by factors including the advent of innovative and advanced technologies, significant investments & government initiatives favoring the biotechnology industry, and rising demand for synthetic biology applications. Biotechnology startups are acquiring robust funding support and venture capital investments, which, in 2021, amounted to USD 41 billion; an increase of over 11% as compared to the previous year's USD 36.7 billion. Notable funding rounds included Caris Life Sciences' $830 million in May 2021 for its precision medicine platform expansion, Abogen's $700 million Series C funding in August 2021 for its COVID-19 vaccine candidate's clinical development, & ElevateBio's $525 million Series C funding in March 2021 for advancing its cell & gene therapy technologies.

In addition, 28 new biotech unicorns were created in 2021, leading to a total of 192 unicorns present in the sector. Government support for the development of biotechnological infrastructure is also contributing to market growth. For instance, India's Union Budget 2021-22 consisted of a provision of USD 227.94 million for biotechnology R&D, along with plans for the setting up of nine biosafety level-3 laboratories in the country. Furthermore, initiatives, such as Illumina Accelerator, are providing access to seed investment, genomics expertise, and Illumina sequencing systems & reagents to selected emerging companies and propelling the market growth.

Due to the COVID-19 pandemic, novel solutions are being explored in the development of vaccines & diagnostic tools for combating the disease. For instance, the advent of mRNA vaccines was supported by cutting-edge technologies in the biotechnology sector, including molecular research tools & genetic sequencing methods that accelerated the timelines for vaccine development. Furthermore, in March 2022, the Diagnostic Analyzer for Specific Hybridization (DASH), a highly sensitive and easy-to-perform PCR test for COVID-19, received FDA emergency use authorization. The test is commercialized by Minute Molecular Diagnostics and can deliver results within 15 minutes. Such advancements in molecular diagnostics are expected to fuel market growth.

Biotechnology Market Report Highlights:

  • The health application segment accounted for the largest share in 2021 due to high disease prevalence, increasing focus on regenerative medicines, innovations in technologies fueled by the COVID-19 pandemic, and improvements in healthcare infrastructure
  • The DNA sequencing technology segment accounted for the second-largest share in 2021 as a result of declining costs of sequencing and its increasing adoption in precision medicine development
  • North America held the largest share of the global market in 2021 owing to the launch of advanced biotechnological solutions facilitated by key players operating in the region
  • Asia Pacific is expected to register the fastest CAGR from 2022 to 2030 due to promising government initiatives and favorable regulatory changes in drug approval processes in India and China

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Assumptions
  • 1.2 Research Methodology
  • 1.3 Information Procurement
  • 1.4 Information or Data Analysis
  • 1.5 Market Formulation and Validation
  • 1.6 Global Market: CAGR Calculation
  • 1.7 Objectives
    • 1.7.1 Objective 1
    • 1.7.2 Objective 2
  • 1.8 Revenue Modeling: Post-COVID-19 Market Scenario
    • 1.8.1 Present market dynamics assessment: Company evaluation
    • 1.8.2 Market dynamics assessment: future projections
    • 1.8.3 Top 20 operational entities: Company revenue & market value analysis
      • 1.8.3.1 Part A
      • 1.8.3.2 Part B
      • 1.8.3.3 Part C

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Market Variables, Trends, and Scope

  • 3.1 Market Trends and Outlook
  • 3.2 Market Segmentation and Scope
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Presence of favorable government initiatives
      • 3.3.1.2 Rising demand for agro-based products
      • 3.3.1.3 Growing demand for synthetic biology
      • 3.3.1.4 Declining prices of DNA sequencing
      • 3.3.1.5 Growing healthcare expenditure boosting development of effective personalized diagnostic & therapeutic procedures for cancer
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Ethical & legal limitations
      • 3.3.2.2 Risks associated with GM organisms and crops
      • 3.3.2.3 Challenges associated with NGS implementation
  • 3.4 Penetration and Growth Prospect Mapping for Technology, 2021
  • 3.5 Market Share Analysis, 2021
  • 3.6 Business Environment Analysis
    • 3.6.1 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
    • 3.6.2 Porter's Five Forces Analysis

Chapter 4 Biotechnology Categorization: Application Estimates & Trend Analysis

  • 4.1 Biotechnology Market: Application Movement Analysis
  • 4.2 Health
    • 4.2.1 Pre-COVID Segment Scenario
    • 4.2.2 Post-COVID Segment Scenario
    • 4.2.3 Global health Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.3 Food & Agriculture
    • 4.3.1 Pre-COVID Segment Scenario
    • 4.3.2 Post-COVID Segment Scenario
    • 4.3.3 Global Food & Agriculture Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.4 Natural Resources & Environment
    • 4.4.1 Pre-COVID Segment Scenario
    • 4.4.2 Post-COVID Segment Scenario
    • 4.4.3 Global Natural resources & environment Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.5 Industrial Processing
    • 4.5.1 Pre-COVID Segment Scenario
    • 4.5.2 Post-COVID Segment Scenario
    • 4.5.3 Global Industrial processing Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.6 Bioinformatics
    • 4.6.1 Pre-COVID Segment Scenario
    • 4.6.2 Post-COVID Segment Scenario
    • 4.6.3 Global Bioinformatics Biotechnology market, 2018 - 2030 (USD Billion)
  • 4.7 Other Applications
    • 4.7.1 Global Biotechnology market for applications, 2018 - 2030 (USD Billion)

Chapter 5 Biotechnology Market Categorization: Technology Estimates & Trend Analysis

  • 5.1 Biotechnology Market: Technology Movement Analysis
  • 5.2 DNA Sequencing
    • 5.2.1 Pre-COVID Segment Scenario
    • 5.2.2 Post-COVID Segment Scenario
    • 5.2.3 Global Biotechnology market for DNA Sequencing, 2018 - 2030 (USD Billion)
  • 5.3 Nanobiotechnology
    • 5.3.1 Pre-COVID Segment Scenario
    • 5.3.2 Post-COVID Segment Scenario
    • 5.3.3 Global Biotechnology market for Nanobiotechnology, 2018 - 2030 (USD Billion)
  • 5.4 Tissue Engineering & Regeneration
    • 5.4.1 Pre-COVID Segment Scenario
    • 5.4.2 Post-COVID Segment Scenario
    • 5.4.3 Global Biotechnology market for Tissue engineering and regeneration, 2018 - 2030 (USD Billion)
  • 5.5 Fermentation
    • 5.5.1 Pre-COVID Segment Scenario
    • 5.5.2 Post-COVID Segment Scenario
    • 5.5.3 Biopharmaceutical Manufacturing
    • 5.5.4 Biopharmaceutical & Biotechnology Research
    • 5.5.5 Others
    • 5.5.6 Global Biotechnology market for Fermentation, 2018 - 2030 (USD Billion)
  • 5.6 Cell-based Assays
    • 5.6.1 Pre-COVID Segment Scenario
    • 5.6.2 Post-COVID Segment Scenario
    • 5.6.3 Global Biotechnology market for Cell-based assays, 2018 - 2030 (USD Billion)
  • 5.7 PCR Technology
    • 5.7.1 Pre-COVID Segment Scenario
    • 5.7.2 Post-COVID Segment Scenario
    • 5.7.3 Global Biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
  • 5.8 Chromatography
    • 5.8.1 Pre-COVID Segment Scenario
    • 5.8.2 Post-COVID Segment Scenario
    • 5.8.3 Global Biotechnology market for Chromatography, 2018 - 2030 (USD Billion)
  • 5.9 Other Technologies
    • 5.9.1 Pre-COVID Segment Scenario
    • 5.9.2 Post-COVID Segment Scenario
    • 5.9.3 Global Biotechnology market for Other technologies, 2018 - 2030 (USD Billion)

Chapter 6 Biotechnology Market Categorization: Regional Estimates & Trend Analysis, by Application & Technology

  • 6.1 Biotechnology Share by Regional, 2021 & 2030
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
  • 6.3 Europe
      • 6.3.1Germany
    • 6.3.2 U.K.
    • 6.3.3 France
    • 6.3.4 Italy
    • 6.3.5 Spain
  • 6.4 Asia-Pacific
    • 6.4.1 Japan
    • 6.4.2 China
    • 6.4.3 India
    • 6.4.4 South Korea
    • 6.4.5 Australia
  • 6.5 Latin America
    • 6.5.1 Brazil
    • 6.5.2 Mexico
  • 6.6 Middle East and Africa (MEA)
    • 6.6.1 South Africa
    • 6.6.2 Saudi Arabia

Chapter 7 Competitive Landscape

  • 7.1 Strategy Framework
  • 7.2 Company Profiles
    • 7.2.1 AstraZeneca
      • 7.2.1.1 Company Overview
      • 7.2.1.2 Financial Performance
      • 7.2.1.3 Product Benchmarking
      • 7.2.1.4 Strategic Initiatives
    • 7.2.2 Gilead Sciences Inc.
      • 7.2.2.1 Company Overview
      • 7.2.2.2 Financial Performance
      • 7.2.2.3 Product Benchmarking
      • 7.2.2.4 Strategic Initiatives
    • 7.2.3 Bristol-Myers Squibb
      • 7.2.3.1 Company Overview
      • 7.2.3.1.1 Celgene Corporation
      • 7.2.3.2 Financial Performance
      • 7.2.3.3 Product Benchmarking
      • 7.2.3.4 Strategic Initiatives
    • 7.2.4 Biogen
      • 7.2.4.1 Company Overview
      • 7.2.4.2 Financial Performance
      • 7.2.4.3 Product Benchmarking
      • 7.2.4.4 Strategic Initiatives
    • 7.2.5 Abbott Laboratories
      • 7.2.5.1 Company Overview
      • 7.2.5.2 Financial Performance
      • 7.2.5.3 Product Benchmarking
      • 7.2.5.4 Strategic Initiatives
    • 7.2.6 Amgen Inc.
      • 7.2.6.1 Company Overview
      • 7.2.6.2 Financial Performance
      • 7.2.6.3 Product Benchmarking
      • 7.2.6.4 Strategic Initiatives
    • 7.2.7 Novo Nordisk A/S
      • 7.2.7.1 Company Overview
      • 7.2.7.2 Financial Performance
      • 7.2.7.3 Product Benchmarking
      • 7.2.7.4 Strategic Initiatives
    • 7.2.8 Merck KGaA
      • 7.2.8.1 Company Overview
      • 7.2.8.2 Financial Performance
      • 7.2.8.3 Product Benchmarking
      • 7.2.8.4 Strategic Initiatives
    • 7.2.9 Johnson & Johnson Services
      • 7.2.9.1 Company Overview
      • 7.2.9.2 Financial Performance
      • 7.2.9.3 Product Benchmarking
      • 7.2.9.4 Strategic Initiatives
    • 7.2.10 Novartis AG
      • 7.2.10.1 Company Overview
      • 7.2.10.2 Financial Performance
      • 7.2.10.3 Product Benchmarking
      • 7.2.10.4 Strategic Initiatives
    • 7.2.11 Sanofi
      • 7.2.11.1 Company overview
      • 7.2.11.1.1 Genzyme
      • 7.2.11.2 Financial Performance
      • 7.2.11.3 Product Benchmarking
      • 7.2.11.4 Strategic Initiatives
    • 7.2.12 F. Hoffmann-La Roche Ltd.
      • 7.2.12.1 Company Overview
      • 7.2.12.2 Financial Performance
      • 7.2.12.3 Product Benchmarking
      • 7.2.12.4 Strategic Initiatives
    • 7.2.13 Pfizer Inc.
      • 7.2.13.1 Company overview
      • 7.2.13.2 Financial Performance
      • 7.2.13.3 Product Benchmarking
      • 7.2.13.4 Strategic Initiatives
    • 7.2.14 Lonza
      • 7.2.14.1 Company Overview
      • 7.2.14.2 Financial Performance
      • 7.2.14.3 Product Benchmarking
      • 7.2.14.4 Strategic Initiatives

List of Tables

  • Table 1 Healthcare expenditure levels, 2018 - 2022
  • Table 2 Various approaches in regenerative medicine for dermatological use
  • Table 3 North America: Clinical studies using HCT for hematopoietic and non-hematopoietic conditions
  • Table 4 North America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 5 North America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 6 U.S. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 7 U.S. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 8 Canada biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 9 Canada biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 10 Europe biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 11 Europe biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 12 Germany biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 13 Germany biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 14 U.K. biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 15 U.K. biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 16 France biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 17 France biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 18 Italy biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 19 Italy biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 20 Spain biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 21 Spain biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 22 Asia Pacific biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 23 Asia Pacific biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 24 Japan biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 25 Japan biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 26 Main monographs published in China
  • Table 27 China biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 28 China biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 29 India biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 30 India biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 31 South Korea biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 32 South Korea biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 33 Australia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 34 Australia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 35 Latin America: Current initiatives and opportunities
  • Table 36 Latin America biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 37 Latin America biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 38 Brazil biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 39 Brazil biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 40 Mexico biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 41 Mexico biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 42 MEA biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 43 MEA biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 44 South Africa biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 45 South Africa biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion)
  • Table 46 Saudi Arabia biotechnology market estimates & forecasts, by application, 2018 - 2030 (USD Billion)
  • Table 47 Saudi Arabia biotechnology market estimates & forecasts, by technology, 2018 - 2030 (USD Billion) 
  • Table 48List of companies evaluated for revenue modeling: Post-COVID market scenario
  • Table 49 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
  • Table 50 NIH common fund awards for biomedical research
  • Table 51 Business grants for life science and biotech in Canada
  • Table 52 Applications of bioinformatics tools
  • Table 53 Types of cell-based assays and methods of quantification

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Top 10 companies: Market revenue analysis, 2021 (USD Billion)
  • Fig. 9 Top 10 companies: Market capital analysis, 2021 (USD Billion)
  • Fig. 10 Top 10 companies: Market value analysis, 2021 Vs 2022 (As of January) in USD billion
  • Fig. 11 Market summary, 2021 (USD Billion)
  • Fig. 12 Market trends & outlook
  • Fig. 13 Market segmentation and scope
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Global financings for regenerative medicine, 2018
  • Fig. 16 DNA sequencing: Cost per MB, 2010 - August 2020
  • Fig. 17 Cost of per human genome, 2010 - August 2020
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Side effects of GM foods
  • Fig. 20 Bottlenecks associated with implementation of NGS
  • Fig. 21 Penetration and growth prospect mapping for technology, 2021
  • Fig. 22 Company market share analysis, 2021
  • Fig. 23 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 24 Porter's Five Forces Analysis
  • Fig. 25 Biotechnology market: Application outlook key takeaways
  • Fig. 26 Biotechnology market: Application movement analysis
  • Fig. 27 Advantages of biotechnology
  • Fig. 28 Gene therapy clinical trials number as of February 10, 2021
  • Fig. 29 Global health biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 30 Adoption of GM crops by region (millions of hectares)
  • Fig. 31 Trait enhancement in plants & crops through recombinant DNA technology
  • Fig. 32 Global food & agriculture biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 33 Global natural resources & environment biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 34 Global industrial processing biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 35 Global bioinformatics biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 36 Global biotechnology market for other applications, 2018 - 2030 (USD Billion)
  • Fig. 37 Biotechnology market: Technology outlook key takeaways
  • Fig. 38 Biotechnology market: Technology movement analysis
  • Fig. 39 Matrix of classification of the first, second, and third generation sequencing based on sequencing chemistry
  • Fig. 40 Global biotechnology market for DNA sequencing, 2018 - 2030 (USD Billion)
  • Fig. 41 Breakdown of nanomedicine products in phase III by therapeutic areas
  • Fig. 42 Types of therapeutic nanoparticles
  • Fig. 43 Global biotechnology market for nanobiotechnology, 2018 - 2030 (USD Billion)
  • Fig. 44 Global biotechnology market for tissue engineering and regeneration, 2018 - 2030 (USD Billion)
  • Fig. 45 Benefits of fermented food
  • Fig. 46 Global biotechnology market for fermentation, 2018 - 2030 (USD Billion)
  • Fig. 47 Global biotechnology market for cell-based assays, 2018 - 2030 (USD Billion)
  • Fig. 48 Global biotechnology market for PCR technology, 2018 - 2030 (USD Billion)
  • Fig. 49 Global biotechnology market for chromatography, 2018 - 2030 (USD Billion)
  • Fig. 50 Global biotechnology market for other technologies, 2018 - 2030 (USD Billion)
  • Fig. 51 Regional marketplace: Key takeaway
  • Fig. 52 Biotechnology regional outlook, 2021 & 2030
  • Fig. 53 North America biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 54 U.S. biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 55 Canada biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 56 Europe biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 57 Germany biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 58 U.K. biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 59 France biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 60 Italy biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 61 Spain biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 62 Asia-Pacific biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 63 Japan biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 64 China biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 65 India biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 66 South Korea biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 67 Australia biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 68 Latin America biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 69 Brazil biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 70 Mexico biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 71 Middle East & Africa (MEA) biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 72 South Africa biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 73 Saudi Arabia biotechnology market, 2018 - 2030 (USD Billion)
  • Fig. 74 Strategy framework
  • Fig. 75 Participant categorization